FDA Rejection Of Avastin For Breast Cancer Therapy Would Be ‘Unscientific, Unethical,’ Editorial Says
Feb 26th 2008Drug InformationBreast Cancer
It would “not only be unscientific but unethical” for FDA to reject Genentech’s colon and lung cancer treatment Avastin for use as metastatic breast cancer treatment, a
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
